(RTTNews) - Wednesday, Bio-Techne Corp. (TECH) announced that its shareholders have approved the acquisition of the company by Merck KGaA (MKKGY.PK), Darmstadt, Germany, marking an important milestone toward completing the transaction. The company believes that the acquisition would bring together their complementary and leading life sciences organizations while delivering substantial, near-term cash value to Bio-Techne shareholders. Notably, the waiting period of the proposed acquisition expired on September 18, 2026. The global life sciences company expects the deal to close by late 2026 or early 2027. TECH was trading at $72.60, up 0.06 percent on the Nasdaq. (RTTNews) - Wednesday, Bio-Techne Corp.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。